Results 111 to 120 of about 1,762 (180)

SLAMF receptors: key regulators of tumor progression and emerging targets for cancer immunotherapy. [PDF]

Mol Cancer
Li J, Fan T, Wang D, Xiao C, Deng Z, Cai W, Ji Y, Li C, He J.   +8 more
europepmc   +1 more source

Small molecules targeting the PD-1/PD-L1 axis for cancer immunotherapy. [PDF]

Theranostics
Yin JY, Liu HM, Li SL, Ji XQ, Wang JJ, Fu MJ, Liu CJ, Wang N, Lu GL, Li Y, Liu HM, Zheng YC, Dai XJ, Liu Y.   +13 more
europepmc   +1 more source

Probing the Immunoreceptor Tyrosine-Based Inhibition Motif Interaction Protein Partners with Proteomics. [PDF]

Molecules
Gao Y, Xing S, Hu L.
europepmc   +1 more source

Nanomedicine targeting the PD-1/PD-L1 axis in autoimmune diseases: breaking conventional barriers to restore immune tolerance. [PDF]

J Nanobiotechnology
Xiang G, Cui Y, Wang P, Feng Y, Zhang C, Lou J, Zhou X.   +6 more
europepmc   +1 more source

The Search for Predictive Biomarkers in Response to Immune Checkpoint Inhibitors and Associated Adverse Events. [PDF]

J Pers Med
Agostini M, Traldi P, Hamdan M.
europepmc   +1 more source

Interplay between CD33 and TREM2 in Alzheimer's Disease: Potential Mechanistic Insights into Microglial Function in Amyloid Pathology. [PDF]

ACS Chem Neurosci
Akinluyi ET, Takahashi-Yamashiro K, Connolly MG, Poon WW, Macauley MS.   +4 more
europepmc   +1 more source

Screening of known gut microbiome-derived metabolites in anti-tumor immunity of colorectal cancer. [PDF]

J Immunother Cancer
Zhang X, Li Z, Hua H, Song H, Qian S, Huang X, Ye G, Huang Y, Wang Q, Zheng B, Xu X, Li Y, Zhu Y, Yu L, Hong Y, Yuan H, Zhang J.   +16 more
europepmc   +1 more source

Dissecting the Ability of Siglecs To Antagonize Fcγ Receptors. [PDF]

ACS Cent Sci
McCord KA, Wang C, Anhalt M, Poon WW, Gavin AL, Wu P, Macauley MS.   +6 more
europepmc   +1 more source

Investigating the effect of ceramic fiber on the mechanical properties of glassphalt. [PDF]

Sci Rep
Dehnad MH, Yazdi A, Hamedi GH.
europepmc   +1 more source